Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this study is to determine the 5-day tolerability of one commercially available prebiotic food ingredient, FOS, in healthy human subjects with and without diet control.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fructooligosaccharide (FOS) | Other | Subjects will be required to take 8 grams of FOS per day for a total of 10 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FOS | Dietary Supplement |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of subjects with Adverse Events | 22 days |
| Measure | Description | Time Frame |
|---|---|---|
| The effect of controlling diet on the tolerability of FOS by analyzing the gut microbiome | 22 days |
| Measure | Description | Time Frame |
|---|---|---|
| The effect of FOS on each subject's gut microbiome | 22 days |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kaleido Biosciences | Cambridge | Massachusetts | 02138 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided